Have We Seen the End of the Line for Tax Inversion Deals?

The video discusses the end of corporate mergers for tax reasons, especially in the healthcare sector, due to potential regime changes in Washington. It highlights the public's perception of financial engineering as a shell game, using examples like Warren Buffett's business moves. The discussion shifts to pharmaceuticals, noting their shift from defensive to growth engines due to strong pricing and earnings, despite recent volatility in healthcare stocks.

What trends are expected regarding companies returning to America?

How have pharmaceuticals shifted in their market position over the last 20 years?